References
Gershenwald J, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: The prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999;17:976–983.
Bilchik AJ, Giuliano A, Essner R, et al. Universal application of intraoperative lymphatic mapping and sentinel lymphadenectomy in solid neoplasms. Cancer J Sci Am 1998;4:351–358.
Saha S, Wiese D, Badin J, et al. Technical details of sentinel lymph node mapping in colorectal cancer and its impact on staging. Ann Surg Oncol 2000;7:120–125.
Joosten JJ, Strobbe LJ, Wauters CA, Pruszczysnki M, Wobbes T, Ruers TJ. Intraoperative lymphatic mapping and the sentinel node concept in colorectal carcinoma. Br J Surg 1999;86:482–486.
Moertel CG, Fleming TR, Macdonald JS, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990;322:352–358.
Nakamori S, Kameyama M, Furukawa H, Takeda O, Sugai S, Imaoka S, Nakamura Y. Genetic detection of colorectal cancer cells in circulation and lymph nodes. Dis Colon Rectum 1997;40(10 Suppl):S29–S36.
Liefers GJ, Cleton-Jansen AM, VandeVelde CJH, et al. Micrometastases and survival in stage II colorectal cancer. N Engl J Med 1998;339:223–228.
Jeffers MD, O’Dowd GM, Mulcahy H, et al. The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma. J Pathol 1994;172:183–187.
Cutait R, Venancio AFA, Lopes LC, et al. Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins. Dis Colon Rectum 1991;34:917–920.
Adell G, Boeryd B, Franlund B, et al. Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes’ B colorectal carcinoma: an immunohistochemical study. Eur J Surg 1996;162:637–642.
Wolmark N, Rockette H, Mamounas E, et al. Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes’ B and C carcinoma of the colon: results from national surgical adjuvant breast and bowel project C-04. J Clin Onc 1999;17:3553–3558.
Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988;319:525–532.
Stern HS. Contributions of molecular genetics to the clinical management of colorectal cancer. Am J Surg 1996;171:10–15.
Takahashi Y, Tucker SL, Kitadai Y, Koura AN, Bucana CD, Cleary KR, Ellis LM. Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer. Arch Surg 1997;132:541–546.
Shibata D, Reale MA, Lavin P, et al. The DCC protein and prognosis in colorectal cancer. N Engl J Med 1996;335:1727–1732.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ellis, L.M. A Perspective on Sentinel Lymph Node Biopsy in Colorectal Cancer: The Race Between Surgical Technology and Molecular Oncology. Ann Surg Oncol 7, 475–476 (2000). https://doi.org/10.1007/s10434-000-0475-1
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10434-000-0475-1